JENNIFER SAMPLES: Open Payments
NPI 1427020056 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 75 payments from 14 companies in 2025. Trend: 2023 $1,324 · 2024 $1,145 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $242 |
| PFIZER INC. | 12 | $207 |
| Lilly USA, LLC | 10 | $177 |
| ABBVIE INC. | 10 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $159 |
| Novo Nordisk Inc | 5 | $87 |
| Amgen Inc. | 4 | $76 |
| Exact Sciences Corporation | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: Kerendia, VRAYLAR, BREZTRI, PREVNAR 20, MOUNJARO, JARDIANCE, ELIQUIS, OTEZLA.
Industry payments across NY — which companies pay providers there.
